Ovoca Bio plc
("Ovoca" or the "Company")
Notice of AGM
Dublin, Ireland, November 18, 2024 - Ovoca Bio, a biopharmaceutical company with a focus on women's health, announces that it has posted the Notice of Annual General Meeting ("AGM") to shareholders.
The AGM is convened to be held at Buswells Hotel, 23-27 Molesworth Street, Dublin 2, Ireland on Wednesday 18th December 2024 at 3.00 p.m. The Notice of AGM contains details of all resolutions to be proposed at the AGM.
Copies of the Notice of AGM will also shortly be available on the Company's website, www.ovocabio.com.
End
For further information:
Ovoca Bio plc
Tim McCutcheon (Chief Executive Officer)
Tel +353 1 661 9819
info@ovocabio.com
Davy (Nominated Adviser, Euronext Growth Listing Sponsor and Broker)
Ivan Murphy / Daragh O'Reilly
Tel: +353 1 679 6363
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
